INNV Valuation

InnovAge Holding Corp

Add to Watchlist

Advanced Chart

4.950

+0.32(6.911%)1D

Overview
Forecast
Valuation
Earnings

INNV Relative Valuation

INNV's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, INNV is overvalued; if below, it's undervalued.

Historical Valuation

InnovAge Holding Corp (INNV) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -51.68. The fair price of InnovAge Holding Corp (INNV) is between NaN to NaN according to relative valuation methord.

Relative Value

Fair Zone

NaN-NaN

Current Price：4.95

Fair

25.83

Trailing

Forward

10.80

EV/EBITDA

InnovAge Holding Corp. (INNV) has a current EV/EBITDA of 10.80. The 5-year average EV/EBITDA is -4.55. The thresholds are as follows: Strongly Undervalued below -403.08, Undervalued between -403.08 and -203.81, Fairly Valued between 194.71 and -203.81, Overvalued between 194.71 and 393.98, and Strongly Overvalued above 393.98. The current Forward EV/EBITDA of 10.80 falls within the Historic Trend Line -Fairly Valued range.

21.26

EV/EBIT

InnovAge Holding Corp. (INNV) has a current EV/EBIT of 21.26. The 5-year average EV/EBIT is -472.47. The thresholds are as follows: Strongly Undervalued below -3849.92, Undervalued between -3849.92 and -2161.19, Fairly Valued between 1216.26 and -2161.19, Overvalued between 1216.26 and 2904.99, and Strongly Overvalued above 2904.99. The current Forward EV/EBIT of 21.26 falls within the Historic Trend Line -Fairly Valued range.

0.68

InnovAge Holding Corp. (INNV) has a current PS of 0.68. The 5-year average PS is 1.35. The thresholds are as follows: Strongly Undervalued below -0.81, Undervalued between -0.81 and 0.27, Fairly Valued between 2.43 and 0.27, Overvalued between 2.43 and 3.51, and Strongly Overvalued above 3.51. The current Forward PS of 0.68 falls within the Historic Trend Line -Fairly Valued range.

10.38

P/OCF

InnovAge Holding Corp. (INNV) has a current P/OCF of 10.38. The 5-year average P/OCF is 71.36. The thresholds are as follows: Strongly Undervalued below -227.19, Undervalued between -227.19 and -77.91, Fairly Valued between 220.63 and -77.91, Overvalued between 220.63 and 369.91, and Strongly Overvalued above 369.91. The current Forward P/OCF of 10.38 falls within the Historic Trend Line -Fairly Valued range.

14.44

P/FCF

InnovAge Holding Corp. (INNV) has a current P/FCF of 14.44. The 5-year average P/FCF is -68.95. The thresholds are as follows: Strongly Undervalued below -326.44, Undervalued between -326.44 and -197.70, Fairly Valued between 59.80 and -197.70, Overvalued between 59.80 and 188.54, and Strongly Overvalued above 188.54. The current Forward P/FCF of 14.44 falls within the Historic Trend Line -Fairly Valued range.

InnovAge Holding Corp (INNV) has a current Price-to-Book (P/B) ratio of 2.85. Compared to its 3-year average P/B ratio of 2.58 , the current P/B ratio is approximately 10.49% higher. Relative to its 5-year average P/B ratio of 1.78, the current P/B ratio is about 60.50% higher. InnovAge Holding Corp (INNV) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -2.63%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -1.67% , the current FCF yield is about -100.00% lower.

2.85

P/B

Median3y

2.58

Median5y

1.78

4.24

FCF Yield

Median3y

-2.63

Median5y

-1.67

Competitors Valuation Multiple

The average P/S ratio for INNV's competitors is , providing a benchmark for relative valuation. InnovAge Holding Corp Corp (INNV) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 11.04%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

INNV.O

InnovAge Holding Corp

Nexxen International Ltd

Definitive Healthcare Corp

Performance Decomposition

Market capitalization of INNV decreased by 17.50% over the past 1 year. The primary factor behind the change was an decrease in Margin Expansion from -1.13 to -2.26.

The secondary factor is the Revenue Growth, contributed 11.04%to the performance.

Overall, the performance of INNV in the past 1 year is driven by Margin Expansion. Which is more sustainable.

11.04%

199.40M → 221.42M

Revenue Growth

100.00%

-1.13 → -2.26

Margin Expansion

-128.54%

77.46 → -22.11

P/E Change

-17.50%